[{"Assets_0_Q3_USD":52673000.0,"CommonStockSharesOutstanding_0_Q3_shares":10237247.0,"NetIncomeLoss_1_Q3_USD":-5273000.0,"NetIncomeLoss_3_Q3_USD":-6527000.0,"StockholdersEquity_0_Q3_USD":50198000.0,"Ticker":"KRYS","CIK":"1711279","name":"KRYSTAL BIOTECH, INC.","OfficialName":"Krystal Biotech Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1834745088.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171113"}]